1. Ben-Jonathan, N., and Hnasko, R. (2001) Dopamine as a prolactin (PRL) inhibitor, Endocr. Rev., 22, 724–763.
2. Bjorklund, A., and Lindvall, O. (1984) Dopamine-containing systems in CNS, in Handbook of Chemical Neuroanatomy (Bjorklund, A., and Hokfelt, T., eds.) Vol. 2, Elsevier, Amsterdam, pp. 55–122.
3. Dahlstrm, A., and Fuxe, K. (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons, Acta Physiol. Scand., 232, S1–S55.
4. Hoookfelt, T., Johansson, O., and Goldstein, M. (1984) Central catecholamine neurons as revealed by immunohistochemistry with special reference to adrenaline neurons, in Handbook of Chemical Neuroanatomy (Bjorklund, A., and Hokfelt, T., eds.) Vol. 2, Elsevier, Amsterdam, pp. 157–276.
5. Ugrumov, M. V. (2013) Brain neurons partly expressing dopaminergic phenotype: location, development, functional significance, and regulation, Adv. Pharmacol., 68, 37–91.